Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, cytotoxicity screening and molecular docking of new 3-cyanopyridines as survivin inhibitors and apoptosis inducers
Rehab Sabour, Marwa F. Harras, Ahmed B. M. Mehany
Bioorganic Chemistry (2019) Vol. 94, pp. 103358-103358
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Pyridine Derivatives as Biologically Active Precursors; Organics and Selected Coordination Complexes
Ezzat Khan
ChemistrySelect (2021) Vol. 6, Iss. 13, pp. 3041-3064
Closed Access | Times Cited: 87
One-pot synthesis of novel poly-substituted 3-cyanopyridines: Molecular docking, antimicrobial, cytotoxicity, and DFT/TD-DFT studies
Islam M. Abdellah, Mohamed R. Eletmany, Antar A. Abdelhamid, et al.
Journal of Molecular Structure (2023) Vol. 1289, pp. 135864-135864
Closed Access | Times Cited: 21
Unveiling the anticancer potential and toxicity of Ganoderma applanatum wild mushroom derived bioactive compounds: An in vitro, in vivo and in silico evaluation
Akbar Rijia, Raman Krishnamoorthi, Pambayan Ulagan Mahalingam, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108233-108233
Closed Access
Pyridine Moiety: An Insight into Recent Advances in the Treatment of Cancer
Rakesh Sahu, Rakhi Mishra, Rajnish Kumar, et al.
Mini-Reviews in Medicinal Chemistry (2021) Vol. 22, Iss. 2, pp. 248-272
Closed Access | Times Cited: 28
Drug screening and biomarker gene investigation in cancer therapy through the human transcriptional regulatory network
Zihao He, Kai Gao, Lei Dong, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1557-1572
Open Access | Times Cited: 10
Theoretical studies, anticancer activity, and photovoltaic performance of newly synthesized carbazole-based dyes
Mohamed R. Elmorsy, Ehab Abdel‐Latif, Hatem E. Gaffer, et al.
Journal of Molecular Structure (2022) Vol. 1255, pp. 132404-132404
Closed Access | Times Cited: 17
Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study
Samy Mohamady, Ahmed Khalil, Bassem H. Naguib, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106988-106988
Closed Access | Times Cited: 9
Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors
Amr K.A. Bass, El-Shimaa M. Nageeb, Mona S. El‐Zoghbi, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105564-105564
Closed Access | Times Cited: 22
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
A review: Biological activities of novel cyanopyridine derivatives
Yurou Wu, Tao Wu, Yong Huang
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 7
Design and synthesis of novel pyridopyrimidine derivatives with anchoring non-coplanar aromatic extensions of EGFR inhibitory activity
Amal A.M. Eissa, Kholoud F.M. Aljamal, Hany S. Ibrahim, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105318-105318
Closed Access | Times Cited: 18
Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective
Qingbin Cui, Caoqinglong Huang, Jingyuan Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16515-16545
Closed Access | Times Cited: 7
3-Cyano-2-oxa-pyridines: a promising template for diverse pharmacological activities
Amr K.A. Bass, Elshimaa M. N. Abdelhafez, Mona S. El‐Zoghbi, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2021) Vol. 4, Iss. 2, pp. 81-86
Open Access | Times Cited: 16
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives
Omkulthom Al Kamaly, Najla Altwaijry, Rehab Sabour, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 4
Closed Access | Times Cited: 17
Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: Design, Synthesis, Radiolabeling, Biodistribution, and Molecular Modeling Simulation
Basem Mansour, Yomna A. Salem, Khaled M. Attallah, et al.
ACS Omega (2023) Vol. 8, Iss. 22, pp. 19351-19366
Open Access | Times Cited: 5
Nicotinonitrile as an essential scaffold in medicinal chemistry: an updated review (2015– present)
Heba Hassan, Mohamed Hisham, M.S. Osman, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2022) Vol. 6, Iss. 1, pp. 1-11
Open Access | Times Cited: 9
Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers
Rehab Sabour, Marwa F. Harras, Omkulthom Al Kamaly, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 4892-4892
Open Access | Times Cited: 13
Design synthesis and cytotoxicity studies of some novel indomethacin-based heterocycles as anticancer and apoptosis inducing agents
Marwa F. Harras, Rehab Sabour, Yousry A. Ammar, et al.
Journal of Molecular Structure (2020) Vol. 1228, pp. 129455-129455
Closed Access | Times Cited: 9
Synthesis and Biological Activities of Heterocyclic Hybrids Containing Piperidine and Pyridine Moieties: Recent Developments
Gangotri Pemawat, Ayushi Bhatnagar, Rama Kanwar Khangarot
Mini-Reviews in Organic Chemistry (2023) Vol. 21, Iss. 3, pp. 346-369
Closed Access | Times Cited: 3
Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAFV600E: Design, Synthesis, and Antiproliferative Activity
Lamya H. Al-Wahaibi, Mohamed Hisham, Hesham A. Abou‐Zied, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1522-1522
Open Access | Times Cited: 2
Molecular docking and anticancer evaluation of some newly synthesized 4-aryl-2-(2-oxopropoxy)-6-(cyclohexyl)nicotinonitrile and their furo[2,3-b]pyridine derivatives
Hanan A. Soliman, Ahmed H. Shamroukh, Eman R. Kotb, et al.
Journal of Molecular Structure (2022) Vol. 1263, pp. 133148-133148
Closed Access | Times Cited: 4
A two-step resin based approach to reveal survivin-selective fluorescent probes
Andrew J. Ambrose, Nhan T. Pham, Jared Sivinski, et al.
RSC Chemical Biology (2020) Vol. 2, Iss. 1, pp. 181-186
Open Access | Times Cited: 5
Isobavachalcone induces apoptosis of colorectal cancer cells mediated by interaction with survivin: Experimental and theoretical analyses
Zhang Li, Bo Yi, Jing Chen
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 9, pp. 105861-105861
Open Access
Exploring the anticancer potential of new 3‐cyanopyridine derivatives bearing N‐acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties
Ibtissem Kadi, Güldeniz Şekerci, Houssem Boulebd, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 9
Open Access
Synthesis and In Silico Docking of New Pyrazolo[4,3-e]pyrido[1,2-a]pyrimidine-based Cytotoxic Agents
Mabrouk Horchani, Niels V. Heise, Sophie Hoenke, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10258-10258
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top